Based on Network Pharmacology to Explore the Mechanisms of Radix Astragali Combined with Prepared Radix Rehmanniain for Treating Osteoporosis
Abstract Background: With the improvement of people's living standards, the aging population in China has gradually increased, and the treatment of osteoporosis (OP) has become a major problem afflicting the medical field. Radix Astragali(RA) and Prepared Radix Rehmannia(PRR) are commonly used Chinese herbal medicines. The combination of them can achieve a synergistic effect in the treatment of osteoporosis. However, its mechanism of action remains uncertain.Objective: This study aims to investigate the possible molecular mechanism of RA combined with PRR in the treatment of OP using an integrated strategy of network pharmacology and experimental validation.Methods: The active ingredients of RA combined with PRR were searched and screened by TCMSP database, and the targets of active ingredients were predicted and supplemented by TCMSP and SwissTargetPrediction databases. The target genes related to OP diseases were searched in GeneCards and OMIM comprehensive databases. The intersection targets of drugs and diseases were imported into String database to obtain the interaction information of intersection target genes. Cytoscape3.7.1 software was used to construct the protein interaction network diagram and "drug component-target-disease" network diagram. Then DAVID database was used for GO gene enrichment analysis and KEGG metabolic pathway analysis. Finally, in vivo experiments were also performed to validate the findings of network pharmacology.Results: A total of 98 active components of RA combined with PRR were finally retrieved and integrated into the TCMSP database, 1700 target genes related to OP were obtained through the disease database, 149 gene targets were obtained by taking the intersection of disease genes, and drug targets, 122 core targets and 514 interaction relationships were obtained after protein interaction network and topology analysis. GO analysis and KEGG pathway enrichment analysis showed that RA combined with PRR intervention for OP mainly through multiple pathways such as PI3K-Akt, MAPK, TNF, Rap1, and Toll-like receptors. In addition, in vivo experiments confirmed that RA combined with PRR could significantly increase bone mineral density, reduce bone spacing, improve bone tissue structure, and improve osteoporosis in ovariectomized rats.Conclusion: In this study, the network pharmacological approach was used to reveal the potential targets and key signal pathways of RA combined with PRR in treating osteoporosis. This study was also verified by animal experiments, which provided a reliable basis for clinical application.